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Abstract
This study aimed to investigate the effects of nonsurgical periodontal therapy on white blood cell (WBC) count and levels of transforming growth factor beta (TGF-β)
in serum from subjects with severe periodontitis. Serum from 28 subjects with periodontitis (mean age: 34.36±6.24; 32% men) and 27 healthy controls (mean age:
33.18±6.42; 33% men) were collected prior to therapy. Blood samples were obtained from 23 subjects who completed therapy (9-12 months). A well-controlled
periodontal treatment protocol was established in three stages: mechanical periodontal therapy (scaling and root planning), reinstrumentation of dental sites, and supportive periodontal therapy. Periodontal and systemic parameters such as the total number of WBCs and TGF-β levels, accessed by enzyme-linked immunosorbent
assay (ELISA), were included. After therapy, all clinical periodontal parameters decreased (p<0.0001). There were no statistical differences in WBC count between
experimental and control groups before or after therapy. However, after therapy, the mean value of lymphocytes in patients with localized aggressive periodontitis
(LAgP) was statistically higher than that of patients with generalized chronic periodontitis (GCP) (p<0.0357). Additionally, TGF-β levels in LAgP and GCP patients
were higher compared to controls before therapy (p<0.05 and p<0.01, respectively). In LAgP patients, periodontal therapy was associated with increased number of
lymphocytes.
Key words: Inflammation; periodontitis; leukocyte count; transforming growth factor beta.

Introduction
Periodontal diseases are characterized as the pathological manifestation of the host immune response to the
bacterial infection at the tooth/gingival interface. These
are mainly caused by Gram-negative bacteria, including
Porphyromonas gingivalis (Pg), Prevotella intermedia,
Aggregatibacter actinomycetemcomitans (Aa), and Tannerella forsythia. Individual response variations can be
explained by a combination of factors that confer upon
them a complex nature. Among these factors, susceptibility becomes prominent, with special attribution given
to genetic polymorphisms, environmental factors and
pathogen virulence factors (1, 2). Individuals affected
by the disease share common polymorphisms in specific genes that are important for the regulation of the inflammatory response (3, 4). However, the determinants
for the susceptibilty of periodontitis are not well defined
(5).
Severe periodontitis affects up to 15% of most populations (6). In Brazil, the most recent National Survey
of Oral Health reported that the distribution of the most
severe forms of periodontal disease is more significant
in adults between 35-44 years of age, with a prevalence
of 19.4% (7).
The term periodontitis generically comprises of
chronic forms of periodontal disease, which is the result
of a polymicrobial infection and is characterized by the
loss of collagen fibers and insertion in the cementum
surface (mineralized tissue that covers the root surface),
apical migration of junctional epithelium (epithelium
continuous with the oral epithelium that promotes the
Copyright © 2015. All rights reserved.

insertion of the gum to the tooth), periodontal pocket
formation (cementum surface devoid of periodontal
fibers) and alveolar bone reabsorption. Such damage
compromises the function of the periodontal tissues and
may result in tooth loss (1).
More than 700 bacterial species can occupy periodontial pockets (8), and a combination of aerobic and
anaerobic microbiota is typically seen in infection. Substantial tissue destruction in patients with severe periodontitis is characterized, in many cases, by the presence of deep periodontal pockets around many or all
the teeth. The aggregated epithelial lesions equal in size
to an ulcerated wound with an area of 8 to 20 cm2, in
accordance with clinical estimations (9). However, the
disease can remain asymptomatic for decades, during
which time its detection is performed only by clinical
examination with periodontal probe and/or intraoral xrays (9). Thus, the chronic and cyclical nature of periodontal disease provides an opportunity for continuous
hematogenous dissemination of periodontal pathogens,
bacterial antigens and inflammatory mediators (5, 10).
Since the beginning of the 1990s, evidence has
pointed to periodontitis as a risk factor for systemic
conditions, such as cardiovascular disease (CVD), adverse outcomes of pregnancy, diabetes and lung disease (11). Recently, a review of the evidence on associations between periodontitis and systemic diseases and
conditions, particularly respiratory disease, chronic
kidney disease, rheumatoid arthritis, cognitive impairment, obesity, metabolic syndrome and cancer was also
published. There was strong evidence that improving
oral hygiene has positive effects on the prevention of
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nosocomial pneumonia. The published evidence supports modest correlations between periodontitis and
chronic kidney disease and obesity and weak correlations between periodontitis and cognitive impairment,
rheumatoid arthritis and metabolic syndrome (5). In this
context, the increase in the number of white blood cells
(WBC) is associated with the increased risk of coronary
heart disease, CVD, atherosclerosis, thrombosis and
myocardial ischemia. This increase may be caused by
the inflammatory nature of chronic infections such as
periodontitis (12).
The T cells CD4+ CD25+ that express transcription
factor Foxp3 are regulatory T cells (Tregs) that prevent
the overreactive adaptive immune response and may be
associated with periodontal disease and its alleviation.
These specifically regulate the activation, proliferation
and effector function of activated T cells and the restoration of homeostasis after infection (13). In the presence of Tregs, a reduction in the levels of interferon
gamma (IFN-γ), interleukin (IL) -17, tumor necrosis
factor (TNF) and IL-1β is observed at murine and canine periodontal disease sites (14). Cytokines produced
by Tregs are IL-10, transforming growth factor beta
(TGF-β) and cytotoxic T-lymphocyte-associated protein
4 (CTLA-4), which, in general, subregulate inflammation. IL-10, TGF-β1 and CTLA-4 are reported to slow
the progression of periodontal disease (5). In addition to
the protective role in periodontal tissue damage, Tregs
also play an important role in immune tolerance (15).
Also, TGF-β has been studied as a form of treatment
in the context of the healing and regeneration of periodontal bone (14). For example, Tregs negatively modulates proinflammatory cytokines responsible for the
inhibition of various processes during the regeneration
of tissue.
Nonsurgical periodontal therapy acts to reduce inflammation markers in the blood (C-reactive protein
[CRP], IL-6, etc.) and reveals some important aspects
of the systemic reach of periodontal inflammation (4,
15-17). Thus, based on the concept of the resolution of
disease, it was established in this study that periodontal
therapy would be considered complete only after confirming the remission of clinical signs of inflammation
such as the absence of bleeding on probing (BOP) and
residual periodontal pockets. However, it is emphasized
that the mechanical removal of the biofilm by scaling
and root planning, with or without another supporting
modality, does not mean that, at any magnitude, inflammation / infection does not persist. Sometimes the removal of local factors is only achieved after repeated
specific actuations principally at sites in which there still
exist clinical signs of inflammation. Sites with residual
periodontal pockets that continue bleeding on probing
undoubtedly require new instrumentation (scaling and
root planning) and reinforcement of oral hygiene instruction. Moreover, the need for reinstrumentation and
clinical response are unique to each individual patient
and for this reason, there is no way to generically establish the completion of therapy for all patients at the
same time.
The goal of this study was to investigate the effects of
severe periodontitis as well as the contributions of nonsurgical periodontal therapy on the systemic inflammatory response regarding the serum levels of TGF-β and
Copyright © 2015. All rights reserved.

WBC count. Furthermore, the relationship between the
number of lymphocytes, serum levels of TGF-β, and
subgroups of severe periodontal disease (generalized
aggressive periodontitis [GAgP], localized aggressive
periodontitis [LAgP] and generalized chronic periodontitis [GCP]) was explored. For this, the individual
response of each patient to therapy was considered, in
respect to the time needed to resolve inflammation in
each individual and, from this, the establishment of supportive periodontal therapy (SPT), also known as periodontal maintenance.
Materials and methods
Subjects and study groups
The study protocol was approved by the Ethics Committee of the Faculty of Health Sciences - University of
Brasília, Brazil (045/2008). All subjects were informed
about the purpose of the study, both orally and written,
and an informed consent document prior to participation was also signed. The clinical trial was registered at
http://www.clinicaltrials.gov.br/, No. RBR-24T799.
The total sample (convenience sampling) consisted
of 55 systemically healthy subjects. The periodontitis
group (PG) consisted of 19 women (68%) and nine men
(age range 20-45; mean age: 34.36±6.24), with ≥18
teeth. The classification of periodontal disease was according to Armitage and Cullinan (18). Chronic periodontitis (CP), with a higher prevalence in adults, can
also occur in children and adolescents. In this, there is
correlation between the severity of bone destruction and
quantity of dental biofilm and calculus, in addition to
the moderate growth rate in the majority of cases. CP is
classified as localized when less than 30% of dental sites (mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual) are affected, and as generalized
(GCP) when it exceeds this limit. LAgP is characterized
by the destruction of the periodontal tissues located in
the first molar / incisor with interproximal insertion loss
in at least two permanent teeth, one of which is the first
molar, and involving no more than two teeth beyond
the first molars and incisors. This is normally detected
and diagnosed during puberty in systemically healthy
individuals. The GAgP usually affects individuals under age 30, but can affect older individuals. The loss of
interproximal insertion is characterized as generalized
when it affects at least three permanent teeth, in addition
to the first molars and incisors. In addition, the AgP is
characterized by a rapid loss of clinical attachment and
alveolar bone.
The control group (CG) consisted of 18 women (67%)
and nine men (age range 21-44; mean age: 33.18±6.42)
with clinical probing depth (PD) ≤3mm and clinical attachment level (CAL) ≤ 3mm, ≤ 10% of sites with BOP,
and no radiographic evidence of bone loss (Figure 1).
Exclusion criteria were history of smoking, pregnancy
or lactation, periodontal therapy, antimicrobial therapy
for systemic conditions or use of topical oral antibiotics in the last twelve months, diabetes, autoimmune disease, acute infections, severe allergies, gastrointestinal
and renal diseases, cancer, morbid obesity (body mass
index [BMI] >40kg/m2) or underweight (malnourished
BMI <18.5kg/m2) (19), and use of medications that alter
the levels of inflammatory mediators.
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Figure 1. Study design. GCP - generalized chronic periodontitis;
GAgP - generalized aggressive periodontitis; LAgP - localized aggressive periodontitis.

Clinical examination
The clinical examination performed at baseline and
after six months of SPT included detection of visible
plaque accumulation described as plaque index (PI)
(20), BOP (20), PD and CAL. Measurements were assessed at four sites around each tooth, buccal, lingual
and both proximal sites using a manual probe (probe
Michigan O with Williams markings) excluding third
molars. Clinical examination was performed by a single
experienced examiner. The calibration and measurements for PD and CAL were repeated within 24 h and
demonstrated a concordance rate above 80%. The BOP
was calculated by Kappa coefficient and the intra-examiner agreement was > 0.85.
Treatment protocol and laboratory analysis
PG subjects were treated in three stages: mechanical periodontal therapy (scaling and root planning) with
Gracey curettes (5/6, 7/8, 11/12, 13/14), reinstrumentation of sites and SPT. The first stage was carried out in
≤14 days. One month later, in stage 2, new mechanical
instrumentation was performed in patients who persisted with deep pockets, BOP and calculus. At this stage,
meticulous scaling and root planning were performed
until the following periodontal conditions were reached:
PD greater than 4mm in at least three or fewer sites, PD
greater than 5mm in two places at most, PI ≤ 15% and
BOP ≤ 10%. In Stage 3, subjects were scheduled biweekly or monthly, according to the need to control biofilm formation. SPT was performed for six months. CG
subjects received oral hygiene instruction at baseline.
Out of the 28 subjects in the PG (14 patients diagnosed with GCP; 8 GAgP patients; 6 LAgP patients),
five did not complete the treatment. Twenty-three completed the three stages of periodontal protocol (12 GCP
patients, 5 GAgP patients and 6 LAgP patients). Among
these, ten subjects (43%) completed the treatment in
nine months, ten subjects (43%) in ten months, and
three subjects (14%) in 12 months.
Blood samples were collected for biochemical analysis at baseline for all 28 PG subjects and 27 CG subjects. Subsequent blood samples were collected from 23
PG subjects who completed treatment in their respective time periods after the beginning of treatment: 9
months (ten individuals), 10 months (ten individuals)
and twelve months (three individuals). Blood was collected in gel separator tubes between 7 and 8 h. Each
Copyright © 2015. All rights reserved.

EDTA tube was analyzed within three hours in order to
perform blood counts with standard measurements for
the number of neutrophils, lymphocytes, monocytes,
basophils and eosinophils. Plasma and serum samples
were immediately placed on ice and stored at -80°C.
Serum levels of TGF-β were detected by enzymelinked immunosorbent assay (ELISA) according to the
manufacturer’s instructions (R&D Systems). Briefly,
96-well plates were coated with anti-human TGF-β.
After blocking for 2 h to avoid non-specific binding,
the standard cytokine provided with the kit or serum
samples were inserted. The cytokine was detected by
horseradish peroxidase-labeled monoclonal antibody
specific to the target after anti-human biotinylated antibodies were placed in each well and incubated for 2 h
at room temperature. The microplate was washed to remove unbound enzyme-labeled antibodies. The amount
of horseradish peroxidase bound to each well was determined by the addition of a substrate solution. The reaction was stopped by the addition of 1 M sulfuric acid,
and the plates were read at 492 nm in a microplate reader (Thermo Scientific). The concentrations of TGF-β in
each sample were determined by interpolation from a
standard curve and presented as picograms per milliliter
(± standard deviation). Serum levels of IL-6 were also
investigated but were non-detectable in the samples.
Statistical analysis
The clinical periodontal parameters PI, PD (≤3, 5
and 6mm) and BOP prior to and post-therapy in the
PG were compared by paired Student’s t-test, as well
as lymphocytes, monocytes, neutrophils and total white
blood cells. In both periods evaluated for this group, a
nonparametric Wilcoxon test was used for the following
variables: number of teeth (NT), PD = 4 and ≥7 mm,
eosinophils and basophils. The measurements NT, PI,
BOP and hematological characteristics were compared
between both groups before and after therapy by Student’s t-test for variables that showed the Gaussian distribution. In cases where normality was not observed
for both groups, the nonparametric Mann-Whitney test
was used. Data were analyzed by SAS 9.2 for Windows.
For purposes of analysis, a significance level of 5% was
used (p<0.05).
To avoid interference of periodontal disease classification in the interpretation of the results, comparisons of the mean values of the variables studied in
post-treatment between the three types of periodontitis (GCP, GAgP, LAgP) from the periodontitis group
were made. Thus, comparisons of all tested measures
cited above were made using the analysis of covariance
model (ANCOVA). The value of the measurement after
therapy was considered as the dependent variable and
the value of the measurement at baseline was the auxiliary variable. Tukey’s adjustment was used to adjust for
three multiple comparisons and pre-specified contrasts
were used to test three hypotheses: first, the mean values in GAgP subgroup do not significantly differ from
the mean values in LAgP subgroup; second, the mean
values in GAgP subgroup do not significantly differ
from the mean values in the GCP subgroup; and third,
the mean values in LAgP subgroup do not significantly
differ from the mean values in the GCP subgroup. For
the age variable, comparisons were made of the mean
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Table 1. Clinical oral parameters before and after supportive periodontal therapy.

Control
(n=27)
28.78±2.01
4.74±2.30
2.67±1.49

Pre-therapy
(n=28)
27.25±4.84
63.61±33.64
44.46±29.35

Post-therapy
(n=23)
24.70±5.79
4.83±6.73
1.63±3.35

p value
pre x post
0.00011
<0.00012
<0.00012

p value
control x pre
0.53173
<0.00013
<0.00013

p value
control x post
0.02943
0.06793
<0.00013

100.00±0.00
0.00±0.00
0.00±0.00
0.00±0.00

68.71±14.38
4.02±4.02
17.08±8.85
10.45±8.89

98.32±1.79
0.63±0.96
0.85±1.22
0.17±0.61

<0.00012
<0.00011
<0.00012
<0.00011

NA
NA
NA
NA

NA
NA
NA
NA

100.00±0.00
0.00±0.00
0.00±0.00
0.00±0.00

62.56±18.20
4.97±4.77
18.74±8.96
13.73±11.49

NA
NA
NA
NA

NA
NA
NA
NA

NA
NA
NA
NA

NA
NA
NA
NA

Parameters*
NT
PI (%)
BOP (%)
PD (mm)
≤3 mm
4 mm
5-6 mm
≥7 mm
CAL (mm)
≤3 mm
4 mm
5-6 mm
≥7 mm

*Results shown as mean ± standard deviation (SD).
1
Wilcoxon test; 2pair T test; 3Mann-Whitney test; NA – not apllicable.
NT - number of teeth, PI - plaque index, BOP - bleeding on probing, PD - probing depth, CAL - clinical attachment level.
Table 2. Hematologic parameters before and after supportive periodontal therapy.

Control
(n=27)

Pre-therapy
(n=28)

Post-therapy
(n=23)

p value
pre x
post

p value
control x
pre

p value
control x
post

Eosinophils (mm3)
references 45 a 400

143.74±102.00

227.96±179.80

178.26±95.26

0.16661

0.05493

0.25483

Basophils (mm3)
references 0 a 100

14.19±31.35

8.71±21.97

13.30±21.30

0.21881

0.57653

0.60333

Lymphocytes (mm3)
references 900 a 3300

2238.52±520.45

2136.75±508.12

2075.22±550.65

0.30182

0.46634

0.28704

Monocytes (mm3)
references 90 a 800

428.22±141.26

368.75±128.59

366.65±138.50

0.51872

0.10824

0.12774

Neutrophils (mm3)
references 2295 a 6500

3208.56±865.86

3548.64±1279.78

3104.59±1496.55

0.08712

0.32794

0.80494

Total Leukocytes (mm3)
references 4500 a 10000

6171.48±1260.51

6297.50±1515.88

5970.00±1734.72

0.18082

0.73934

0.63734

Parameters*

*Results shown as mean ± standard deviation (SD).
1
Wilcoxon test; 2pair T test; 3Mann-Whitney test; 4T test.

values after therapy among the three groups using the
analysis of variance model (ANOVA). Tukey’s adjustment was used to adjust for three multiple comparisons,
and pre-specified contrasts were used to test the same
above-mentioned three hypotheses. A comparison of the
proportion of males, as well as females, between groups
was tested using the chi-square test.
Finally, serological data, pre- and post-therapy, in
reference to the quantification of TGF-β by ELISA were
analyzed by ANOVA following a criterion of Tukey’s
post-test in GraphPad Prism (v5.0). For purposes of
analysis, a significance level of 5% was used (p<0.05).
Results
Demographic, hematological characteristics and clinical oral parameters of the study population, before
and after nonsurgical periodontal therapy
Initially, 28 patients with periodontitis were involved
in this study (32% men; mean age: 34.36±6.24) and 27
healthy controls (33% men; mean age: 33.18±6.42).
There was no difference between PG and CG for age
(p=0.4955) and gender (p=0.9251). Of all the patients in
the PG, 23 were followed until remission of periodontal
disease. Clinical oral parameters prior to and post-SPT
Copyright © 2015. All rights reserved.

are shown in Table 1.
In the PG, nonsurgical periodontal therapy led to a
significant decrease in all clinical periodontal parameters (p<0.0001). At baseline, the CG was significantly
different from the PG for PI and BOP (p<0.0001). The
mean values for PI and BOP in the PG were greatly reduced after the therapy.
As shown in Table 2, there were no statistical differences in hematological parameters between the PG and
the CG before or after therapy. In addition, these parameters for the PG were not modified after nonsurgical
periodontal therapy.
Among the 23 individuals who completed treatment, 12 presented GCP (8 women and 4 men; mean
age: 37.17±1.63), five, GAgP (4 women and 1 man;
mean age: 31.60±2.53) and six LAgP (4 women and 2
men; mean age: 30.67±2.31). The values for the age, as
well as the proportion of males and females in the PG
after therapy did not differ among the three periodontitis subgroups (p=0.553 and p=0.8485, respectively).
Since the PG in this study consisted of three subgroups
of severe periodontitis, comparisons were made of the
mean values post-treatment between these subgroups
for the above-mentioned measures (Tables 3 and 4).
It was observed that except for lymphocytes cells, the
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Discussion

mean values did not significantly differ among the three
subgroups of severe periodontitis (GCP; GAgP; LAgP).
However, the mean value corresponding to the lymphocyte cells in the LAgP subgroup was statistically higher
than the mean value in the GCP subgroup (p<0.0357),
with no statistically significant difference between the
other subgroups. The mean values for lymphocyte cells
in three subgroups, in descending order, were LAgP >
GCP > GAgP.

In individuals susceptible to periodontitis, unnatural
resolution of periodontal inflammation results in chronic inflammation, which may have a systemic impact (5,
21-25). The acute inflammatory response is protective,
but a failure to remove the inflammatory cells, especially neutrophils, characterize chronic, pathological
and destructive lesions (5). Therefore, it is evident that
the three aspects of the pathogenesis of periodontitis
(infection, inflammation and adaptive immunity) have
a potential role and impact on the systemic immunoinflammatory response, which either initiate or mediate a
wide range of systemic diseases (5).
In a previous study by our group, we found levels of
high-sensitivity C-reactive protein (hs-CRP) > 0.3 mg/
dL in individuals with severe periodontitis compared to
controls (60.87 versus 23.08, respectively; p=0.0216)
(7) and periodontal therapy was associated with a decrease in hs-CRP levels circulating in serum and an
increase in high density lipoprotein.
This study investigated the WBC count in peripheral

ELISA before and after nonsurgical periodontal therapy
In the PG, samples of the disease groups (LAgP,
GAgP, GCP) showed a higher amount of TGF-β before
nonsurgical periodontal therapy, however, there was no
significant difference when the TGF-β levels were compared before and after therapy for all groups (Figure 2).
In addition, TGF-β levels were significantly higher in
patients with LAgP (p<0.05) and GCP (p<0.01) compared to controls prior to nonsurgical periodontal therapy. IL-6 was not detectable in any disease group and
analyzed time.

Table 3. Clinical oral parameters before and after supportive periodontal therapy in periodontitis subgroups.

periodontitis subgroups*
Variables

GAgP

LAgP

GCP

NT
PI (%)
BOP (%)
PD (mm)
≤3 mm
4 mm
5-6 mm
≥7 mm

22.81 ± 1.09
9.71 ± 2.18
3.22 ± 1.26

24.79 ± 1.01
3.26 ± 2.02
1.61 ± 1.16

25.43 ± 0.72
3.57 ± 1.41
0.98 ± 0.77

Comparison
between
subgroups –
F test†
0.1722
0.0624
0.3304

98.16 ± 0.77
0.89 ± 0.45
1.63 ± 0.54
0.06 ± 0.30

98.66 ± 0.75
0.43 ± 0.42
0.07 ± 0.53
-0.05 ± 0.27

98.21 ± 0.47
0.63 ± 0.29
0.91 ± 0.35
0.33 ± 0.18

0.8742
0.7568
0.1719
0.4406

p value
GAgP
vs
LAgP§
0.3736
0.1035
0.6541

GAgP
vs
GCP§
0.1551
0.0701
0.3012

LAgP
vs
GCP§
0.8729
0.9916
0.8946

0.9029
0.7364
0.1480
0.9664

0.9984
0.8791
0.5138
0.7131

0.8702
0.9204
0.4220
0.4794

* Values plus or minus are the adjusted mean ± standard error.
†
p-values calculated using ANCOVA; § p-values between subgroups calculated using ANCOVA. Multiple comparisons were adjusted by
Tukey's test.
GAgP - generalized aggressive periodontitis, LAgP - localized aggressive periodontitis, GCP - generalized chronic periodontitis.
NT - number of teeth, PI - plaque index, BOP - bleeding on probing, PD - probing depth.
Table 4. Hematologic parameters before and after supportive periodontal therapy in periodontitis subgroups.
periodontitis subgroups*

p value

GAgP

LAgP

GCP

GAgP
vs
LAgP§

GAgP
vs GCP§

LAgP vs
GCP§

Eosinophils (mm3)
references 45 a 400

Comparison
between
subgroups – F
test†

143.65 ± 41.92

214.29 ± 38.38

174.67 ± 27.30

0.4625

0.4374

0.8143

0.6887

Basophils (mm3)
references 0 a 100

16.62 ± 8.64

10.92 ± 7.92

13.11 ± 5.68

0.8840

0.8741

0.9411

0.9740

1939.53 ± 153.83

2397.50 ± 132.14

1970.61 ± 89.95

0.0372

0.1100

0.9840

0.0357

384.91 ± 57.47

353.58 ± 54.42

365.58 ± 36.34

0.9282

0.9234

0.9556

0.9823

Neutrophils (mm3)
references 2295 a 6500

3397.12 ± 903.39

2890.54 ± 542.42

3153.11 ± 391.02

0.8672

0.8785

0.9684

0.9205

Total Leukocytes (mm3)
references 4500 a 10000

6028.84 ± 628.26

6124.48 ± 593.06

5868.24 ± 411.66

0.9360

0.9933

0.9751

0.9357

Variables

Lymphocytes (mm3)
references 900 a 3300
Monocytes (mm3)
references 90 a 800

* Values plus or minus are the adjusted mean ± standard error.
†
p-values calculated using ANCOVA; § p-values between subgroups calculated using ANCOVA. Multiple comparisons were adjusted by Tukey's
test.
GAgP - generalized aggressive periodontitis, LAgP - localized aggressive periodontitis, GCP - generalized chronic periodontitis.
Copyright © 2015. All rights reserved.

76

A. C. E. Leite et al. / Periodontal Therapy on Leukocytes Count and TGF-β Levels.

Figure 2. Serum levels of TGF-β pre and post-treatment. TGF-β transforming growth factor beta.

blood and TGF-β levels in the three severe periodontitis
groups (GAgP, LAgP e GCP) as well as the effects of
nonsurgical periodontal therapy on them. It was noted
that the chronic lesions of human periodontal disease
showed an increased expression of regulatory cytokines
such as TGF-β (26). Although Tregs and Th17 cells perform different roles in the pathogenesis of infection, it
has been shown that there is a reciprocal path of development. Naive T cells exposed to TGF-β upregulate
Foxp3 and become induced Tregs, but when cultured
with TGF-β and IL-6, the naive T cells generate Th17
cells with pathological activities (osteoclastogenesis).
Thus, when the immune response is not activated, TGF-β promotes the generation of induced Tregs that suppress inflammation. However, when an infection is established, for example, during the gingivitis or early stage of periodontitis, IL-6 is synthesized during the innate
immune response by inhibiting the generation of Tregs
and inducing the differentiation of Th17 cells that are
pro-inflammatory and pro-resorptive in the presence of
TGF-β (27). It is also known that the absence of Tregs,
it is an indication for a great variety of disorders, such as
autoimmunity, dermatitis, periodontitis and even transplant rejection. A potential treatment option for these disorders revolves around increasing the number of Tregs
in local sites (28, 29).
This study demonstrated, prior to the nonsurgical
periodontal therapy, an increase in TGF-β levels in the
serum of patients with LAgP and GCP compared to controls (Figure 2). This suggests a systemic effect of the
disease, where TGF-β in periodontitis patients appears
as a molecular component associated with the immunosuppression of the inflammatory response, as TGF-β
levels were higher in patients with LAgP and GCP than
in the controls. IL-6 levels are not shown here in the results, since this cytokine was not detectable in the samples. Since the prevalence of LAgP is low (18, 30), the
adopted grouping criterion also allowed the obtainment
of a larger number of individuals with severe disease
in the periodontitis group (Tables 1 and 2). However,
the analysis of these individuals, also in periodontitis
subgroups (LAgP, GAgP e GCP), becomes justified by
previous studies (30-32) having shown a biological distinction in relation to systemic inflammatory markers
between the AgP and CP.
WBC count is characterized as a crude marker of
systemic inflammation and correlates to the host response with respect to a variety of stimuli. This marker
has also been associated with a significant prediction of
future cardiovascular events and glucose intolerance in
different populations (33, 34).
Copyright © 2015. All rights reserved.

The number of eosinophils, basophils, lymphocytes,
monocytes, neutrophils and total leukocytes found in
patients with severe periodontitis in this study (Table 2)
did not set any leukocytosis frame, indicating that systemic inflammation raised by periodontal infection was
not well pronounced. This also suggests that in general,
participants in the study were systemically healthy, and
nonsurgical periodontal therapy produced no change in
leukocyte differential counts.
These data confirmed the results of earlier studies
(35, 36) showing that peripheral blood mononuclear
cells from patients with periodontitis did not proliferate
in response to bacterial antigens. However, other studies
(37, submitted paper in J. Investig. Clin. Dent. 2014,
Oct 6) have confirmed an increased number of WBCs
and neutrophils in the peripheral blood of patients with
moderate to severe periodontitis, with a positive correlation between disease severity and number of WBCs
in the blood. It was recently demonstrated a significant
increase in the number of neutrophils in the peripheral
blood of patients with GAgP (submitted paper in J. Investig. Clin. Dent. 2014, Oct 6). In the present study, after nonsurgical periodontal therapy, the number of lymphocytes in patients with LAgP was statistically higher
than patients with GCP (p <0.0357) (Table 4). Among
the other subgroups (GAgP versus LAgP and GAgP
versus GCP) there was no statistically significant difference (Table 4). The lymphocyte numbers in the three
subgroups were, in descending order, LAgP > GCP >
GAgP, similar to that reported by a previous study (38).
These authors compared the composition of gingival
lesions of 21 patients with CP and six LAgP children.
Reviews of the stereological and histochemical analysis showed that lymphocytes and B cells, in particular,
occupied fractions of volume significantly greater in
the LAgP than in the CP. Also, Cairo et al. (2010) (31)
found a strong antibody response in the serum for infectious agents in LAgP and poor antibody response in the
serum for GAgP.
As for the effects of nonsurgical periodontal therapy
on clinical periodontal parameters, a significant decrease became clear in all of them (p <0.0001) (Table 1).
It should be noted that there was a significant reduction of PI from 63.61±33.64 to 4.83±6.73 and of BOP
from 44.46±29.35 to 1.63±3.35. After therapy, the NT
was statistically fewer due to the extraction of periodontally condemned teeth (p =0.0001) (Table 1). This set
of measures relating to active periodontal therapy and
SPT ensured adequate clinical response to all patients.
Furthermore, such conduct allowed for a more accurate
verification of the effects of therapy on TGF-β levels
and WBC count and thus confirm the role of severe periodontitis in systemic inflammation.
Additionally, rigorous therapeutic protocols and periodontal maintenance contributed to the restoration of
phagocytic function in peripheral blood neutrophils (39)
and reduction of hs-CRP levels in patients with severe
periodontitis (7). These findings also support the conclusions of D’Aiuto et al. (2004) (16, 17) and Kamil et
al. (2011) (40) when reporting a greater reduction in the
levels of systemic inflammatory markers among those
with better clinical responses to periodontal therapy.
It should be noted that an interpretation of the results of related studies becomes difficult due to some
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methodological differences between them. Small sample sizes, non-comparable study populations in terms of
age, ethnicity, geographic location, as well as different
measures and definitions of periodontitis are aspects
that make it difficult to compare results (41). Likewise, parameters used to assess the effects of periodontal
treatment and improvement in the levels of circulating
biomarkers differ among studies (22, 42).
A unique feature of the biofilm of the oral cavity,
particularly the subgingival biofilm, is its close proximity to highly vascularized tissues. Any disruption of
natural integrity of the subgingival epithelium, whose
thickness is at most 10 layers, can lead to bacteremia
(43). Likewise, in periodontitis the periodontal pocket
epithelium is typically thin and ulcerated and, therefore, often opens, allowing access of pathogens to the
connective tissue and blood vessels. In patients with
moderate to severe periodontitis, the total area of the
pocket epithelium in direct contact with the subgingival
biofilm is surprisingly large, reaching to about the size
of the palm of the human hand or much larger in advanced cases (44). Therefore, both the access of microorganisms to the bloodstream and the onset of chronic
inflammation with area and intensity sufficient to elicit a
significant host response provides the basis for the study
of the inter-relationship between periodontitis and CVD
and obesity, among others. Thus, the complexity of the
processes involved in the immunological host response
leads to differences in the manifestation and progression
of periodontitis (45), which leads to the need of different therapeutic approaches.
Since periodontitis is characterized as a polymicrobial infection, pathogens can modulate the T cell response to promote its own adaptability, and the immune
response itself becomes a mixture of immunological
responses mediated by all the microorganisms represented in the biofilm (45, 46). Therefore, it may not be possible to reliably dissect patterns of dominant activities
of Th1, Th2, Th17 or Tregs among the diseased periodontal tissue samples collected. Thus, it may be simpler
and more productive to consider the roles of each cytokine (Th1, Th2, Th17 or Tregs) in periodontal infection, since the performance of T cells in the maintenance of homeostasis between the biofilm microorganisms
and host becomes remarkable.
It is unclear which specific signaling pathways need
to be blocked or enhanced to mitigate the disease in order to promote host defense. Moreover, the modulation
of the host immune system through drugs may result in
adverse side effects, requiring close monitoring of this
approach (28). Therefore, additional studies are needed
to understand the onset and progression of periodontitis
and develop therapeutic interventions to control them.
In conclusion, this study demonstrated in systemically healthy patients with severe periodontitis (LAgP,
GAgP and GCP) a decrease of all local clinical signs
of inflammation after periodontal therapy. Moreover,
periodontal therapy was associated with lower levels of
TGF-β in comparison to those before the treatment, although not statistically significant for all disease groups.
Also, after the treatment, the number of lymphocytes
in patients with LAgP was statistically greater than the
number of lymphocytes in patients with GCP. Nonsurgical periodontal therapy based on the reduction and reCopyright © 2015. All rights reserved.

mission of the clinical signs of inflammation in the local
sites of disease and significant improvements in the biological markers of inflammation in the peripheral blood
requires efficient control of the formation of dental biofilm which can only be monitored through rigorous SPT
with frequent and individualized therapeutic interventions for each patient in treatment and maintenance.
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